Please assess the completion status of the following clinical trial:

Trial Title: Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female (negative pregnancy test required for females of childbearing potential) ≥ 18 years of age and capable of signing informed consent;~* Typical chest discomfort at rest; lasting at least 5 minutes in the prior 24 hours that is highly suggestive of myocardial ischemia and is not explained by trauma or obvious abnormalities on chest x-ray;~* Two or more of high-risk clinical features.~Exclusion Criteria:~* Clear indication for low molecular weight or unfractionated heparin;~* Pregnancy;~* Increased bleeding risk;~* Impaired hemostasis;~* Angina from a secondary cause;~* Inability to commence ST segment monitoring within 4 hours of study drug initiation;~* Uninterpretable ST segment based upon baseline 12-lead ECG;~* Any contraindications to treatment with LMWH (or unfractionated heparin), including heparin induced thrombocytopenia, known allergy to heparin, low molecular weight heparin, pork or pork products;~* Renal insufficiency or renal dialysis;~* A prosthetic heart valve;~* Any other clinically relevant serious diseases;~* Current evidence of inebriation with alcohol or intoxication resulting from other drug abuse;~* Treatment with other investigational agents or devices within the previous 30 days, planned use of investigational drugs or devices, or has previously enrolled in this trial;~* Inability to comply with the protocol;~* Inability to understand the nature, scope, and possible consequences of the study or is otherwise unable to provide informed consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).